The deubiquitinating enzyme BAP1 possesses growth inhibitory activity and functions as a tumor suppressor. In this study, we report that BAP1 also plays positive roles in cell proliferation.
The deubiquitinating enzyme BAP1 possesses growth inhibitory activity and functions as a tumor suppressor. In this study, we report that BAP1 also plays positive roles in cell proliferation.
BAP1 depletion by RNAi inhibits cell proliferation as does overexpression of a dominant negative mutant of BAP1. Mass spectrometry analyses of copurified proteins revealed that BAP1 is associated with factors involved in chromatin modulation and transcriptional regulation. We show that the interaction with HCF-1, a cell cycle regulator composed of HCF-1N and HCF-1C, is critical for the BAP1-mediated growth regulation. We found that HCF-1N is modified with K48-linked polyubiquitin chains on its Kelch domain. The HCF-1 binding motif (HBM) of BAP1 is required for interaction with HCF-1N and mediates deubiquitination of HCF-1N by BAP1. The importance of the BAP1-HCF-1 interaction is underscored by the fact that growth suppression by the dominant negative BAP1 mutant is entirely dependent on the HBM. These results suggest that BAP1 regulates cell proliferation by deubiquitinating HCF-1.
Post-translational modification of proteins with ubiquitin is a crucial regulatory mechanism in many cellular processes. Like other posttranslational modifications, ubiquitination is a reversible process. The human genome encodes nearly 100 potential deubiquitinating enzymes that are classified into five different families (1) . These deubiquitinating enzymes are highly specialized and involved in diverse cellular processes such as cell-cycle regulation, gene expression, DNA repair, signal transduction, and protein trafficking (2) (3) (4) (5) (6) . Importantly, deubiquitinating enzymes appear to be involved in disease-related pathways as exemplified by the genetic alterations of deubiquitinating enzyme genes in various types of cancer (7) . Although it is becoming clear that deubiquitinating enzymes play critical roles in various cellular pathways, physiological roles for most of the human deubiquitinating enzymes remain unknown.
BRCA1-associated protein 1 (BAP1) was originally discovered as an interactor of a tumor suppressor protein, BRCA1 (8) . BAP1 is a deubiquitinating enzyme in the ubiquitin Cterminal hydrolase (UCH) family and accumulating evidence suggests that BAP1 functions as a tumor suppressor: first, BAP1 enhances BRCA1-mediated growth suppression (8) ; second, mutations and deletions in the BAP1 gene have been reported in breast and lung cancers (8) (9) (10) ; and third, restoration of BAP1 in a BAP1-null lung cancer cell line suppresses cell growth and tumorigenicity (11) . In addition to its growth-suppressive function in cancer cells, BAP1 may play a role in the normal cell cycle. BAP1 depletion by RNA interference (RNAi) has been shown to cause cell-cycle defects such as slow S-phase progression or accumulation of S and G2/M phase cells (12, 13) . Although all these facts suggest that BAP1 is important to ensure proper cell proliferation, the underlying molecular mechanism for BAP1-mediated growth control is still unclear.
Host cell factor-1 (HCF-1) is an important regulator of cell proliferation (14, 15) . It is a heterodimer of HCF-1N and HCF-1C, which are produced by proteolytic processing of a large precursor protein (16) (17) (18) . HCF-1 plays critical roles at the multiple stages of the cell-cycle; HCF-1N is essential for G1 phase progression, while HCF-1C is important for proper cytokinesis (15) . HCF-1 is a chromatin-bound protein and association with chromatin is dependent on the presence of the intact Kelch domain at the Nterminus of HCF-1N (19) . The Kelch domain binds to target proteins by recognizing a conserved peptide sequence, (D/E)HXY, known as the HCF-1-binding motif (HBM) (20, 21) . A number of transcription factors contain an HBM and recruit HCF-1 to promoters to regulate transcription (22) (23) (24) (25) . HCF-1 is also known to associate with histone-modifying complexes such as the Set1/Ash2 histone methyl transferase complex, the Sin3/HDAC histone deacetylase complex, and MOF histone acetyl transferase (26) (27) (28) (29) . By functioning as a scaffold to recruit histone-modifying enzymes to promoters, HCF-1 regulates gene expression through selective modulation of chromatin structure (22, 30) .
We previously developed RNAi-based screening for genes important for cell proliferation (31) . We applied this RNAi screening strategy to the subfamily of deubiquitinating enzymes to identify those important for cell proliferation. In this study, we investigated molecular mechanisms of growth control by one of the identified genes, BAP1. We found that BAP1 is associated with chromatin-related proteins including HCF-1. BAP1 binds HCF-1 via its HBM and negatively regulates the ubiquitination levels of HCF-1N. We propose that deubiquitination of HCF-1 is a crucial step in BAP1-mediated growth regulation.
EXPERIMENTAL PROCEDURES

Cell culture
Human breast epithelial cell line MCF10A was cultured in DMEM/F12 containing 5% donor calf serum, 0.02 μg/ml EGF (BD Biosciences), 1 μg/ml Insulin (Sigma), 1.4 μM hydrocortisone (Sigma) and 0.1 μg/ml Cholera toxin. Human embryonic kidney cell line 293T was cultured in RPMI1640 supplemented with 10% fetal bovine serum. For transient expression of proteins, 293T cells were transfected with plasmids using Lipofectamine 2000 (Invitrogen). Retroviruses were produced in a packaging cell line, 293GPG, or by transfecting retroviral and packaging plasmids to 293T cells. Cells were infected with supernatants containing retroviruses in the presence of 4 μg/ml Polyblene (Sigma) and selected with 1 μg/ml puromycin (Sigma) for 48-72 hr. Infected cells were cultured in the absence of puromycin at least for 24 hr for recovery from drug selection.
RNA interference
Short hairpin RNAs (shRNAs) were expressed as a part of a mir30 precursor (32) . The target sequences of shRNAs are: shControl, CGUACGCGGAAUACUUCGA; shBAP1.214, CGACCUUCAGAGCAAAUGU; shBAP1.321, CGUCCGUGAUUGAUGAUGA; shBAP1.2132, GAGUUCAUCUGCACCUUUA.
Plasmids
Full-length BAP1 cDNA was amplified by RT-PCR using LA Taq (Takara) from MCF10A mRNAs and cloned into the following mammalian expression vectors: pcDNA3.1/Zeo, pEG2-Flag, pEG2-Flag-2NLS, pEF4H (for 4xHA tag), pMMP-puro, pBABE-puro/3xFlag-His 8 . HCF-1N fragments and HCF-1C were amplified from pAPN-HA-HCF-1 (a gift from Winship Herr) and cloned into pEG2-Flag-2NLS and pEG2-Flag, respectively.
For construction of retroviral vectors expressing shRNAs, hairpin sequences were cloned into pENTRmir, which contains a mir30 precursor sequence between attL1 and attL2. mir30 cassettes harboring an shRNA were transferred by LR recombination into pMMP-puro-DEST, which was created by inserting a Gateway destination cassette (Invitrogen) in the multi-cloning site of pMMPpuro. Site-directed mutagenesis was performed by pfuTurbo (Stratagene) and all introduced mutations were confirmed by sequencing. Plasmids for ubiquitin mutants were reported previously (33) .
GST pull-down assays
GST-fusion proteins were produced in E. coli BL21(DE3). In vitro translation of HCF-1N was performed in the presence of [ 35 S]methionine (Perkin Elmer) using the TNT Quick Coupled Transcription/Translation System (Promega) according to the manufacturer's instruction. For GST pull-down assays, GST-fusion proteins (5 μg) were incubated with glutathione beads (Sigma) in GST binding buffer (20 mM Tris-HCl (pH7.4), 150 mM NaCl, 1.0% NP-40, 25 μg/ml BSA) for 1 hr at 4°C. Beads were then incubated with 15 μl of in vitro translation products in GST binding buffer for 2 hr at 4°C followed by five washes with GST binding buffer. Proteins bound to the beads were eluted by boiling in 2×SDS-PAGE sample buffer. After SDS-PAGE, GSTproteins were visualized by Coomassie Brilliant Blue staining and 35 S-labeled proteins were detected by autoradiography.
Western blotting and immunoprecipitation
Cells were lysed in NP-40 lysis buffer (50 mM Tris-HCl (pH7.4), 150 mM NaCl, 0.1% NP-40, 5 mM EDTA, 50 mM NaF, 1 mM Na 3 VO 4 , 10% Glycerol) supplemented with protease inhibitor mix (Sigma). Cell fractionation was performed essentially as described previously (34) . For Western blotting, 30 μg of proteins were separated by SDS-PAGE, transferred to nitrocellulose membrane, and probed with antibodies. Antibodies used for Western blotting: anti-BAP1 (Santa Cruz), anti-β-actin (Sigma), anti-ERK (Cell Signaling), anti-Flag (Sigma), anti-HA (Santa Cruz), anti-HCF-1C (a gift from Winship Herr), anti-ORC2 (BD Biosciences). Anti-HCF-1N was raised by immunizing rabbits with GST-HCF-1 (961-1011). For immunoprecipitation, cell lysates containing ~2 mg proteins were mixed with antibodies for 2 hr to overnight and immuno-complexes were precipitated with protein A or protein GSepharose beads (GE Helthcare). Anti-Flag M2 Affinity agarose gel (Sigma) was used for precipitation of Flag-tagged proteins. In vivo ubiquitination assays were performed essentially as described previously (35) .
Tandem affinity purification
293T cells expressing 3xFlag/His 8 -BAP1 were cultured in ten 15-cm plates and lysed in NP-40 lysis buffer. Cell lysates were incubated with anti-Flag affinity agarose beads (Sigma) for 4 hr and beads were washed 5 times with NP-40 lysis buffer. Purified BAP1 complexes were eluted with 1 mg/ml 3xFlag peptide (Sigma) and subjected to His 8 -tag purification using TALON polyhistidine affinity resin (Clontech) followed by elution with 150 mM imidazole. A small portion of the purified BAP1 complexes was separated by SDS-PAGE and visualized by silver staining. The rest of the samples were precipitated with TCA and analyzed by mass spectrometry.
Mass spectrometry
TCA precipitates were resuspended in digestion buffer (100 mM Tris-HCl, pH 8.5, 8M urea), digested by the sequential addition of lys-C and trypsin proteases, and analyzed using shotgun proteomics methods on a LTQ-Orbitrap mass spectrometer (Thermofisher) as previously described (36) (37) (38) (39) . SEQUEST and DTASelect algorithms were used to identify peptides sequences from tandem mass spectra (40, 41) . Proteins were considered present in a sample if at least two peptides were identified per protein using a peptide level false positive rate of 5% as determined using a decoy database strategy (42) . Proteins were considered to associate with BAP1 if they were present in the BAP1 IP but absent from other control purifications. We excluded common contaminants like ribosomal proteins and keratins.
For ubiquitination site mapping, differential modification searches that considered a mass shift of +114.04292 Da on lysines were utilized. Additionally, cysteine alkylation was performed using chloroacetamide instead of iodoacetamide to prevent the generation of ubiquitin-mimicking adducts chemical adducts as previously described (43) .
RESULTS
BAP1 depletion results in growth retardation
To identify deubiquitinating enzymes important for cell proliferation, we screened all known members of two families of deubiquitinating enzymes, UCH and USP (ubiquitin specific protease), by RNAi using BrdU incorporation assays as a measure of proliferative activity ((31) and unpublished data). BAP1 was among the hit genes that affected incorporation of BrdU after siRNA-mediated depletion in a breast epithelial cell line MCF10A. BAP1 depletion by RNAi also affected proliferation of another breast epithelial cell line MCF12A and breast cancer cell lines MCF7 and T-47D (Fig. S1 ). Furthermore, the negative effect of BAP1 depletion on cell proliferation was recapitulated in cell growth assays using MCF10A and MCF12A cells infected with retroviruses expressing BAP1 shRNAs ( Fig. 1A and Fig. S2 ). Three shRNAs targeting different portions of the BAP1 mRNA efficiently depleted BAP1 proteins and caused growth retardation.
BAP1 is the largest member of the human UCH family. It contains an extended C-terminus, which may be involved in interaction with other proteins. Therefore, overexpression of BAP1 with defective deubiquitinating enzyme activity may have a dominant negative effect by sequestering interactors from endogenous BAP1. Substitution of cystein-91 to serine (C91S) was previously reported to diminish ubiquitin hydrolase activity in vitro (8, 44) . We overexpressed wild-type and the C91S mutant of BAP1 in MCF10A and MCF12A using high titer retroviruses (Fig. 1B) . Expression of the C91S mutant inhibited cell growth whereas wild-type BAP1 did not. From these experiments, we concluded that deubiquitinating activity of BAP1 is required for efficient cell proliferation.
BAP1 associates with chromatin-related proteins and transcription factors in vivo
To better understand the molecular mechanisms underlying BAP1-mediated growth control, we set out to identify new interactors of BAP1. We expressed BAP1 with a 3xFlag/His 8 tag in 293T so that proteins associated with BAP1 would be captured by tandem affinity purification using anti-Flag beads followed by metal affinity resins. SDS-PAGE of the purified proteins revealed specific bands along with 3xFlag/His 8 -BAP1 ( Fig. 2A) , suggesting that BAP1 is associated with other cellular proteins. Using MudPIT (multidimensional protein identification technology) mass spectrometry (36, 37) , we identified peptides present in the protein mixture purified from cells expressing affinity-tagged BAP1 but not in a control sample containing native BAP1. Proteins represented by three or more unique peptides are listed in Table 1 . The identified BAP1-associated proteins were enriched with proteins involved in transcription and chromatin regulation. For instance, HCF-1 has been shown to interact with histone modifying enzymes and to assist in transcriptional regulation through interaction with DNA binding proteins (26) (27) (28) (29) . ASXL1 and ASXL2 are members of the polycomb protein family and contain a PHD domain, which is known to recognize histone methylation (45). Histone-modifying enzymes were also present in the BAP1 precipitates, including the histone acetyl transferase HAT1, as well as AOF1, which was recently shown to possess H3-Lys4 demethylase activity (46) . In addition, several transcription factors including FoxK1 and FoxK2 were coprecipitated with BAP1. This result suggests that BAP1 may be involved in chromatin modulation and gene expression, and prompted us to test whether BAP1 is a chromatin-bound protein. We fractionated cellular proteins into a cytosol (S2) fraction and a nuclear fraction, which was subsequently fractionated into nucleoplasmic (S3) and chromatin-enriched (P3) fractions (Fig. 2B) . Treatment of the nuclei with micrococcal nuclease (MNase) before the fractionation released chromatin-bound proteins such as ORC2 into the nucleosolic fraction (S3).
BAP1 was most abundant in the chromatin-enriched fraction (P3) and solubilized by MNase treatment like ORC2. Thus, consistent with the fact that BAP1 is associated with chromatin-related proteins, the major fraction of BAP1 appears to be present on chromatin.
Interaction of BAP1 and HCF-1
Among the BAP1-associated proteins identified by mass-spectrometry, we focused on HCF-1 because the functions of HCF-1 have been linked with cell growth regulation (14, 15) . We confirmed that HCF-1 depletion by RNAi resulted in growth retardation in MCF10A (data not shown).
We first examined association of endogenous BAP1 and HCF-1 by coimmunoprecipitation (Fig. 3A) . HCF-1 was recovered in BAP1 immunoprecipitation, and BAP1 was coprecipitated with HCF-1 in the reciprocal experiment.
HCF-1 is a hetero-dimer of HCF-1N and HCF-1C, which are produced by processing of the full-length precursor (16) (17) (18) (Fig. 3B) . Because each subunit contains distinct functional domains and play different roles in cell-cycle regulation, we first determined which subunit of HCF-1 interacts with BAP1. Flag-HCF-1N or Flag-HCF-1C was coexpressed with 4HA-BAP1 and immunoprecipitated. We found that 4HA-BAP1 was coprecipitated with HCF-1N but not with HCF-1C (Fig. 3C) . Further, HCF-1N contains an N-terminal Kelch domain and a basic region. To determine the BAP1-interacting domain in HCF-1N, we performed similar coimmunoprecipitation assays using various deletion fragments of HCF-1N. We found that the Kelch domain is sufficient to interact with BAP1 (Fig. 3D) .
We next determined the HCF-1N-binding region of BAP1. Four GST fusion proteins containing different regions of BAP1 were used to perform pull-down assays with HCF-1N produced by in vitro translation.
The fragment corresponding to amino acids 282-434 of human BAP1 is sufficient to associate with HCF-1N (Fig.  4A ). This portion of BAP1 contains a short sequence (residues 356-385) which is highly conserved among species (Fig. 4B and Fig. S3 ). In examining this conserved region, we noted the NHNY sequence, which is similar to HBM (D/EHXY) (Fig. 4B) . Prompted by this finding and the notion that the Kelch domain interacts with BAP1, we hypothesized that the NHNY sequence is required for interaction with HCF-1N. A mutant BAP1 in which the NHNY sequence was substituted with AAAA (BAP1 ∆HBM) was examined for its interaction with endogenous HCF-1. BAP1 ∆HBM as well as BAP1 with a deletion of the conserved sequence (amino acids 356-385) lacks the ability to interact with endogenous HCF-1N in vivo (Fig. 4C) .
A point mutation in the Kelch domain of HCF-1 (P134S) has been shown to disrupt the interaction between the Kelch domain and HBMcontaining proteins (14) . We therefore speculated that interaction of BAP1 with the HCF-1 Kelch domain may also be affected by this mutation if the HBM-like sequence, NHNY, in BAP1 is recognized by the Kelch domain in the same fashion.
Indeed, the mutant Kelch domain (P134S) pulled down substantially less BAP1 protein than wild-type Kelch domain in the coprecipitation assays (Fig. 4D) . Therefore, we concluded that the amino acid sequence NHNY in BAP1 function as an HBM and that the Kelch domain of HCF-1 recognizes and binds this element.
The Kelch domain of HCF-1 is ubiquitinated in vivo at K105, K163, K244 and K363
Because BAP1 is a deubiquitinating enzyme, an interesting possibility is that HCF-1 is ubiquitinated in vivo and the level of ubiquitination is regulated by BAP1. To address this possibility, we first tested whether HCF-1 is ubiquitinated in vivo by ubiquitination assays. Flag-tagged HCF-1N and HA-ubiquitin were coexpressed and Flag-HCF-1N immunoprecipitated under denaturing conditions. Ubiquitin molecules conjugated to HCF-1N were then detected by anti-HA Western blotting. A smear of HA-Ubiquitin signals was detected in the Flag-HCF-1N pulldown, indicating that Flag-HCF-1N is ubiquitinated in vivo (Fig. 5A) . Ubiquitination of HCF-1N was also observed when it was produced by the expression of a full-length HCF-1, which was then processed to the HCF-1N fragment by proteolytic cleavage (Fig. S4) . The Kelch domain appears to be the primary acceptor of ubiquitin in HCF-1N, as similar levels of ubiquitination were detected with HCF-1N and with the Kelch domain by itself (Fig. 5A) . Additionally, Kelch domain may also be sufficient to bind putative E3(s) responsible for this ubiquitination.
We next determined the ubiquitin acceptor sites in the Kelch domain. Flag-Kelch proteins transiently expressed in 293T cells were purified under denaturing conditions, separated by SDS-PAGE, and visualized by Coomassie staining (Fig. 5B) . Besides the non-ubiquitinated form, several discrete bands (indicated as triangles in Fig. 5B ) as well as a smear of proteins were detected specifically in cells expressing FlagKelch.
Mass-spectrometry analysis of these discrete bands revealed ubiquitination at lysine-105, lysine-163, lysine-244 and lysine-363. Kelch domains have a six-bladed β-propeller structure with each blade composed of four β-strands (47). The ubiquitin acceptor sites identified by massspectrometry are located in or close to the loops between β-strands (Fig. 5C) .
Depending on which lysine residue of ubiquitin is utilized for chain formation, different types of polyubiquitin chains direct proteins to distinct fates. For example, K48-linked ubiquitin chains mainly trigger degradation by proteasomes while K63-linked chains are involved in totally distinct processes such as kinase signaling (48) . HCF-1C was recently shown to be conjugated with K48-and K63-linked polyubiquitin chains (12) . We therefore examined the linkage of the polyubiquitin chains on the HCF-1 Kelch domain by using a variety of lysine mutants of ubiquitin in the in vivo ubiquitination assays. Expression of lysine to arginine mutants of ubiquitin inhibits polyubiquitin chain elongation if the mutated lysine residues are used in the normal elongation process. Because ubiquitin is an abundant protein in vivo, expression of ubiquitin mutants are not expected to inhibit elongation completely, but should reduce polyubiquitin chain length due to capping.
First, we examined the effect of the K48R mutant, in which lysine-48 is mutated to arginine. Utilizing this mutant caused an increase of ubiquitinated Kelch proteins in the lowmolecular-weight range (Fig. 5D ), suggesting that lysine-48 is involved in polyubiquitin chain formation on the Kelch domain.
The polyubiquitin chains, however, do not appear to be exclusively K48-linked because the effect of the K48R mutant was not as strong as the K0 mutant. Next, we examined the effect of the ubiquitin K48 mutant, in which all lysine residues except K48 have been substituted with arginines. As such, only K48 and the amino-terminus are available for ubiquitin conjugation. In this case, the K48 mutant did not alter the pattern of Kelch polyubiquitination (Fig. 5D) .
In contrast, expression of the K63 mutant resulted in increase in the hypoubiquitinated forms and the effect was nearly similar to that of the K0 mutant. Based on these results, we concluded that K48 is a major but not exclusive site for polyubiquitin chain linkage on the Kelch domain.
BAP1 deubiquitinates HCF-1N in vivo
Having established assays to determine the ubiquitination levels of HCF-1N in vivo, we next tested whether co-expression of BAP1 affects the ubiquitination level of HCF-1N. Wild-type BAP1 induced a dramatic decrease in the ubiquitination levels of both Flag-HCF-1N and Flag-Kelch (Fig. 6A and Fig. S5, middle panel) . In contrast, the C91S mutant, a catalytically inactive form of BAP1, did not reduce ubiquitination. Rather, BAP1 C91S increased the amount of ubiquitinated Kelch protein in the high molecular weight range. This is likely due to the dominant negative effect of the mutant, caused by interference of the overexpressed variant protein with endogenous BAP1 action. This experiment, therefore, suggests that BAP1 decreases the ubiquitination levels of the HCF-1 Kelch domain.
Next we tested whether direct interaction between BAP1 and HCF-1 is required for the reduction of HCF-1 polyubiquitination by BAP1. First, using in vivo deubiquitination assays, we examined the importance of the HBM for BAP1-mediated reduction of Flag-Kelch domain ubiquitination. Mutations in the HBM abolished BAP1-mediated reduction in the ubiquitination level (Fig. 6B, middle panel) .
Similarly, introduction of the ∆HBM mutation diminished the dominant negative effect of BAP1 C91S on the ubiquitination level of HCF-1 Kelch (Fig. 6C) . These results suggest that the direct interaction between BAP1 and Kelch is required for the BAP1-mediated reduction of HCF-1N ubiquitination. Consistent with this, the Kelch domain harboring the P134S mutation exhibited greater ubiquitination in the in vivo ubiquitination assays (Fig. 6D ) likely due to the weaker association with endogenous BAP1 (Fig. 4D) . In summary, the HBM of BAP1 and P134 of HCF-1 Kelch domain are required for the reduction of HCF-1N ubiquitination by BAP1. Since the UCH activity of BAP1 is also required (Fig. 6A) , we conclude that BAP1 associates with and deubiquitinates HCF-1 in vivo.
The BAP1 HBM is required for BAP1-mediated growth regulation
Biochemical evidence shown above suggests that BAP1 binds to the HCF-1 Kelch domain via HBM and deubiquitinates HCF-1N in vivo. We next determined whether the interaction between BAP1 and HCF-1 is important for the role of BAP1 in cell proliferation. In Figure 1B , we have shown that overexpression of the BAP1 C91S mutant in MCF10A suppresses cell growth. This is a dominant negative effect of the mutant, caused by sequestration of critical substrates from endogenous BAP1. If interaction with HCF-1 is important for BAP1 functions, the HBM would be required for the BAP1 C91S mutant to have a dominant negative effect on cell proliferation. We therefore tested whether deletion of the HBM from the BAP1 C91S mutant abolishes the effect on cell growth. We expressed BAP1 with various combinations of mutations: wild-type, C91S, ∆HBM, C91S/∆HBM (Fig. 7A) . The C91S mutant affected cell growth as expected, whereas BAP1 construct with both C91S and ∆HBM mutations failed to inhibit cell growth (Fig. 7B) . This result indicates that interaction with HCF-1 is essential for BAP1 function in cell growth regulation.
DISCUSSION
BAP1 plays important roles in cell growth and tumor suppression.
In this study, we investigated the molecular mechanisms of BAP1-mediated growth regulation. We reported here that BAP1 is associated with factors involved in chromatin regulation and transcription. While this manuscript was under review, Sowa et al. published a global proteomic analysis of human deubiquitinating enzyme complexes and reported similar BAP1-associated proteins (49) .
We further showed that interaction with HCF-1 is important for BAP1-mediated control of cell growth. HCF-1N is ubiquitinated in vivo and the ubiquitination level is decreased by BAP1. We propose that HCF-1 is a critical target of BAP1 in growth regulation.
Using a targeted siRNA screen, we found that BAP1 is important for cell proliferation. Previous genome-wide RNAi screening performed by another group also identified BAP1 as a gene that is important for cell proliferation in other cell lines (50, 51) . However, it was not clear whether the role of BAP1 in cell proliferation is dependent on its deubiquitinating activity. In this study, we showed, using a dominant negative form of BAP1, that the intact UCH activity of BAP1 is necessary for proper cell proliferation (Fig. 1B) . Several studies have implicated BAP1 in cell-cycle regulation: one study reported that BAP1 depletion slows down S phase, while another showed that BAP1 expression accelerates S phase entry (11, 13) . These facts, therefore, point to the notion that BAP1 is involved in the transition from G1 to S phase. Similarly, HCF-1N has been implicated in G1 phase progression (15) . Thus, BAP1 may control the G1/S transition by regulating the function of HCF-1N. Interestingly, BAP1 is not absolutely essential for cell proliferation. A number of cancer cell lines are viable without BAP1 (8) and the lack of BAP1 is even advantageous to those cells for proliferation and tumor formation (11) . It is likely that those cancer cells have additional genetic or epigenetic alterations in other genes that overcome the requirement of BAP1 for cell proliferation. BAP1 may have dual roles in growth control; it is involved in the regulation of the normal cell cycle while it prevents uncontrolled cell growth, thereby ensuring proper cell proliferation.
Recently, the interaction between BAP1 and HCF-1 was also reported by Misaghi et al. (12) . Consistent with their study, our data indicates that the HCF-1 Kelch domain recognized the noncanonical HBM sequence of BAP1 (Fig. 4) . This conclusion was further strengthened by another experiment in which we showed that the interaction between BAP1 and the Kelch domain was affected by substitution of Proline-134 with serine (P134S), a mutation in the HCF-1 Kelch domain known to disrupt Kelch-HBM interactions (20,21) (Fig. 4D) . The function of the BAP1 HBM is unique among the other known HBMs commonly found in DNA binding proteins (25) because it is used for an enzymesubstrate interaction rather than for tethering HCF-1 to a promoter. Importantly, we further showed that the interaction with HCF-1 is important for regulation of cell growth by BAP1, as the dominant negative effect of BAP1 C91S on cell growth was entirely dependent on the BAP1 HBM (Fig. 7B) . This result links BAP1 enzyme activity with HCF-1 and is in line with the notion that BAP1 is a deubiquitinating enzyme for HCF-1.
We present several lines of evidence to support the idea that HCF-1 is a substrate of BAP1 in vivo. First, BAP1 binds to HCF-1N in vivo ( Fig. 3 and 4) . Second, coexpression of BAP1 reduced ubiquitination levels of the HCF-1N in a UCH-and HBM-dependent manner ( Fig.  6A and 6B) . Third, ubiquitination of the Kelch domain was increased when co-expressed with a dominant negative form of BAP1 (Fig. 6A ) and this effect is dependent on the BAP1-HCF-1 interaction (Fig. 6C) . Fourth, the Kelch domain harboring the P134S mutation, which reduces association between BAP1 and the HCF-1 Kelch domain, exhibited a higher degree of ubiquitination than wild-type (Fig. 6D) . Based on these results, we concluded that BAP1 directly deubiquitinates HCF-1N in vivo, although we cannot exclude the possibility that the effect of BAP1 on the HCF-1 ubiquitination may also be mediated by indirect effects.
Misaghi et al. recently reported that HCF-1C is also ubiquitinated (12), thus HCF-1 appears to be ubiquitinated on both subunits. Our data indicated that the Kelch domain is sufficient for ubiquitination (Fig. 5A) , suggesting that the putative E3 ligase binds to the Kelch domain. Our analysis using ubiquitin mutants revealed that the polyubiquitin chains on the Kelch domain are mainly K48-mediated, but could potentially include other types of linkages as well (Fig. 5D) . Indeed, K48-and K63-linked ubiquitin peptides were detected in the mass-spectrometry analyses of the ubiquitinated Kelch domain shown in Figure 4 (data not shown). In the previous study, the polyubiquitin chains on HCF-1C were reported to be K48-and K63-linked (12) . Because K48-linked polyubiquitin chains are known as a signal for proteasome-dependent degradation, BAP1 may be a stabilization factor for HCF-1. However, we did not observe a reduction in the total levels of HCF-1 subunits after either BAP1 depletion or overexpression of dominant negative BAP1 (unpublished data). Likewise, BAP1 RNAi did not reduce (but instead increased) the HCF-1C levels in the recent report by Misaghi et al. Although we cannot rule out the possibility that BAP1 regulates HCF-1 levels during only a small part of the cell-cycle, on the whole BAP1 appears to control cell growth via deubiquitination of HCF-1 without affecting its overall level. Alternatively, a small fraction of HCF-1 that is bound to a specific promoter may be regulated by BAP1. It is also possible that deubiquitination of HCF-1N may modulate completely different properties of the protein, such as localization of HCF-1 or interactions with Kelch-binding proteins.
In any case, the BAP1/HCF-1 interaction serves to underscore the increasingly complex and dynamic nature of ubiquitination and deubiquitination in the cellular environment.
In summary, we have shown that the BAP1-HCF-1 interaction plays a pivotal role in regulation of cell growth by BAP1. We also showed that HCF-1 is modified with polyubiquitin chains, which are reduced by BAP1. It is worth noting that, although the dominant negative effect of BAP1 C91S on cell growth was totally dependent on the BAP1-HCF-1 interaction, this study does not undermine the potential importance of other BAP1 interactors. BAP1 C91S may have different levels of dominant negative effects on each BAP1 interactor depending on the strength of their respective interactions. Also, BAP1 may have a function independent of its deubiquitinating enzyme activity. Such a function is not expected to be affected by BAP1 C91S overexpression. Further characterization of other BAP1 interactors will be needed for a more complete understanding of BAP function in cell growth and tumor suppression. 
